Print Friendly, PDF & Email

NCT/Study#

NCT03873883 /

IO-001

Phase I/Ib First-In-Human Study Of EOS100850 In Patients With Advanced Solid Tumors

DISEASE GROUP:

Phase 1 Clinical Trials

current phase:

Phase I

STUDY STATUS:

Accepting Patients

Location:

Hackensack, NJ

For More information:

Call 201-518-3587